miR-181a mediates TGF-β-induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer.
about
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "Reactive" Biliary Epithelial PhenotypeCirculating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular CarcinomaMicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancerDysregulation of non-coding RNAs in gastric cancerMicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: results from clinical data set and patients' samplesFlot2 promotes tumor growth and metastasis through modulating cell cycle and inducing epithelial-mesenchymal transition of hepatocellular carcinoma.Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.An integrated analysis of the SOX2 microRNA response program in human pluripotent and nullipotent stem cell lines.Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.LEF1 targeting EMT in prostate cancer invasion is mediated by miR-181a.TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection.RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren's disease.DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma.Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression.MiR-487a Promotes TGF-β1-induced EMT, the Migration and Invasion of Breast Cancer Cells by Directly Targeting MAGI2.Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.Overexpression of TMPRSS4 promotes tumor proliferation and aggressiveness in breast cancermiR-181a involves in the hippocampus-dependent memory formation via targeting PRKAA1.Immortalized Human Hepatic Cell Lines for In Vitro Testing and Research Purposes.MiR-23a promotes TGF-β1-induced EMT and tumor metastasis in breast cancer cells by directly targeting CDH1 and activating Wnt/β-catenin signaling.Computational identification of microRNAs and their targets in liver cirrhosis.Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.Transcriptomic profiling in human mesangial cells using patient-derived lupus autoantibodies identified miR-10a as a potential regulator of IL8.Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.MicroRNA-378 is involved in hedgehog-driven epithelial-to-mesenchymal transition in hepatocytes of regenerating liver.The Role of MicroRNA-181a in Myocardial Fibrosis Following Myocardial Infarction in a Rat Model.Analysis of Transcription Factor-Related Regulatory Networks Based on Bioinformatics Analysis and Validation in Hepatocellular Carcinoma
P2860
Q26765903-BD144A02-2F00-448A-BD89-4DDB450758DBQ26767346-A0768461-8BD1-4B33-A409-96A40E3B9B1DQ26777313-FEB0984E-6457-4B24-AE28-870F33B6A460Q26780293-3EC1E545-617B-47EF-88B5-09E20F6C7819Q30859743-543B30C8-5C40-44D0-BBB9-CA657B1FDBEFQ33732998-CB4947D1-D76F-4755-AD9C-A14C79211243Q33869770-42117FA8-1F47-4148-8DF2-C877D07B9977Q34174419-85CDBFD0-2CA2-4648-A5AE-45A550861589Q35125641-FDB15730-DD6E-44EA-B2D7-B0DC517F5CB8Q35666448-D50F2D64-7D86-46DD-A94C-06A0A1620699Q35865491-A88E2EA2-F90E-4AA7-8BFA-47C0D4164FB9Q36134941-36B0CF53-598D-4164-9EE8-BF8DE24B05A1Q36298188-7852F4D4-6DB3-4A93-ABF1-4D16103C7D48Q36340244-7EF2E35F-7D84-4362-985E-8597377F8172Q36727102-6B26B6AA-DDA9-49B3-ADB3-B8AF07F48306Q37400824-211C4015-0855-4417-AFD2-AD2FB0E0AD8DQ37714123-0997F78A-FAD0-4FE9-A11A-0EA1A9F872F4Q38641480-C7E32F81-4EE9-4DEA-8578-06C3EFEE82C6Q38843888-32BB03BE-86AB-4B8C-9200-C6BF98713E35Q42378357-86107D12-B6F7-4988-8103-FCA564804A1EQ47099635-D9F4D1A7-7080-471E-9F54-148FDE95C986Q47215507-D5AA9DED-7C05-464F-B28D-67ED969B8CDAQ50131911-A6460A9F-00F9-4476-AE66-41654D60BE10Q53031449-96FA1720-3197-4471-9C41-807F570C3F4BQ55450066-94235EF3-1B59-4809-BF23-DA28F1BCE1AEQ55556068-F9C804E7-9382-4804-A5AC-7C606BAB9FFAQ58693451-FF2BCD1E-0DF6-4248-8AC6-E6AFE7C5A2DB
P2860
miR-181a mediates TGF-β-induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
miR-181a mediates TGF-β-induce ...... sis and hepatocellular cancer.
@en
miR-181a mediates TGF-β-induce ...... sis and hepatocellular cancer.
@nl
type
label
miR-181a mediates TGF-β-induce ...... sis and hepatocellular cancer.
@en
miR-181a mediates TGF-β-induce ...... sis and hepatocellular cancer.
@nl
prefLabel
miR-181a mediates TGF-β-induce ...... sis and hepatocellular cancer.
@en
miR-181a mediates TGF-β-induce ...... sis and hepatocellular cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
miR-181a mediates TGF-β-induce ...... sis and hepatocellular cancer.
@en
P2093
Candice A Grzelak
David G Bowen
Jennifer Brockhausen
Jennifer R Gamble
Mathew Vadas
Narcy Teoh
Nick Shackel
William M d'Avigdor
P2860
P304
P356
10.1111/LIV.12517
P577
2014-04-30T00:00:00Z